Moreover, in breast cancer, CXCR4 interacts with the EGFR variant, EGFR vIII, a constitutively active mutant highly expressed in cancer stem cells [135], to regulate invasion via p38 MAPK [136]. The gene discussed is EGFR; the disease is cancer.